65,437 trials
Head Trauma
Primary: Sonographic Evaluation of Cervical Collar Effects on the Optic Nerve Sheath Diameter in Head Trauma Patients — 4.71; 5.19; 5.26 Milimeter
Nocturnal Hypoventilation · Neuromuscular Disease · Chest Wall Disorder
Primary: Overnight Mean Oxygen Saturation — 96; 96 % SaO2 — p=0.13
Triple Negative Breast Cancer
Primary: Number of Participants With Pathologic Response by HR-deficiency (HRD) Status — 9; 2; 10; 4 Participants
Anatomic Total Shoulder Arthroplasty
Primary: Difference in Glenoid Component Placement (Inclination and Version) — 2.0; 5.3 degrees
BRCA or HRR+ Mutated Ovarian Cancer Patients
Primary: Progression-Free Survival (PFS) — 18.0; 16.6 months
Hearing Loss · Emergency Service · Hospital Readmission
Primary: Number of Participants With Use of Hearing Assistance Device (HAD) During Emergency Department (ED) Stay — 38; 25 Participants
Neurofibromatoses
Primary: Part 1: Photosensitizer Uptake and Conversion to Protoporphyrin IX — 304 Densitometry units/micrometer squared — p=0.0001
Diabetes Mellitus, Type 1
Primary: Nucleus Accumbens Blood Flow — 1.13; 1.16; 1.15; 1.21 ml/g/min per ml/g/min
Heart Failure
Primary: Change From Baseline to Week 12 in PCr/ATP Ratio in the Resting State Measured by 31P Cardiac Magnetic Resonance Spectroscopy (MRS). — 0.068; 0.259; -0.179; 0.100 PCr /…
Cerebrospinal Fluid Leaks
Primary: Change in Median (Headache Impact Test-6) HIT-6 Score From Baseline — -12; -7 score on a scale
Prediabetes
Primary: Engagement in Recommended Behaviors to Prevent Type 2 Diabetes — 2; 5; 5; 2 Participants
NSCLC (Advanced Non-small Cell Lung Cancer)
Primary: Progression-Free Survival Following U3-1287 (AMG 888) in Combination With Erlotinib — 1.4; 2.5; 1.6 months
Permanent Atrial Fibrillation
Primary: Patient Reported Quality of Life (SF-36) — 29.7; 31.9 score on a scale
Chronic Rhinitis
Primary: Change in Reflective Total Nasal Symptom Score (rTNSS) — -5.1 units on a scale — p=<0.0001
Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c at 24 Weeks — -0.28; 0.51 percentage of glycated hemoglobin — p=< 0.0001